Name
|
Urotensin II , goby
|
Code
|
|
The alias
|
Urotensin II , goby
|
Sequence (single letter abbreviation)
|
AGTADCFWKYCV (Cys6 and 11 bridge)
|
Sequence (three-letter abbreviation)
|
H-Ala-Gly-Thr-Ala-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH (trifluoroacetate salt)(Cys6 and 11 bridge)
|
A basic description
|
A vasoactive "somatostatin-like" cyclic peptide originally derived from fish spinal cords that has recently been cloned from man. It was found to be the most potent mammalian vasoconstrictor identified so far and may have additional activities, as urotensin II immunoreactivity was also found within the central nervous system and endocrine tissues.
|
solubility
|
|
The molecular weight
|
1361.6
|
Chemical formula
|
C62H84N14O17S2
|
The purity
|
80%,90%,95%,98%,99%
|
Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
Annotation
|
|
Documents
|
|
Figures
|
|
Reference
|
D. Pearson et al., Proc. Natl. Acad. Sci. USA, 77, 5021 (1980)
J.M. Conlon et al., Regul. Peptides, 69, 95 (1997)
|
The C-terminal
|
|
The N-terminal
|
|
Chemical bridge
|
(Cys6 and 11 bridge)
|